Versigent Ltd. (VGNT) PT Raised to $48 at Wells Fargo
Tweet
Share
E-mailGet Alerts VGNT Hot Sheet
Price: $46.41 -2.09%
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
9 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Wells Fargo analyst Colin Langan raised the price target on Versigent Ltd. (NYSE: VGNT) to $48.00 (from $42.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan
- Rubrik Inc (RBRK) PT Raised to $120 at Cantor Fitzgerald Into Q2 Earnings
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
